Our Team

Sign up to receive the latest announcements on Woke Pharmaceuticals....

    Associate Professor Vanessa Beesley

    Principal Investigator

    Associate Professor in behavioural science and Team Head of the Supportive Care in Cancer Group at QIMR Berghofer. Chief investigator of 13 patient-reported outcomes studies. Founding member of the Queensland Collaborative for Cancer Survivorship which focuses on developing and evaluating health innovations.

    Associate Professor Beesley is the Principal Investigator for Woke’s clinical feasibility trial of WP002 for prolonged grief.